Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Olema Pharmaceuticals, Inc. OLMA

Set alert

Price alert · OLMA

All alert types
7.35 USD +0.27 +3.89%

As of Nov 3, 1:24 PM ET

Bid
7.34 × 1
Ask
7.35 × 5
7.00 Day range 7.41
6.24 52-week range 36.26
YTD
-70.62%
1 year
-12.77%
Open
7.12
Prev close
7.07
Mkt cap
641.36M
Vol
470.01K
Avg vol
1.19M
EPS
-2.12
P/E
0.00
Div yield
0.00%
More statistics
Low
7.00
High
7.41
Forward P/E
-4.86
Beta
2.01
Short ratio
7.94
Inst. own
118.48%
Dividend
0.00
Ex-div date
Earnings
Nov 10, 2026
50-d avg
11.34
200-d avg
17.51
1y target
40.70

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 10, 2026Earnings: -0.61; estimate -0.55146; surprise -10.62%
Signals (17)
NameDateAgo
RSI: OversoldOct 23, 20261 week ago
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldOct 1, 20261 month ago
RSI: OversoldSep 28, 20261 month ago
RSI: OversoldSep 23, 20261 month ago
MACD: Sell SignalSep 14, 20261 month ago
MACD: Buy SignalSep 2, 20262 months ago
MACD: Sell SignalAug 28, 20262 months ago
MACD: Buy SignalAug 27, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
SMA: BullishAug 4, 20263 months ago

Analyst view

Price target (mean) 40.70 +454.1% upside
Target (low)
23.00
Target (mean)
40.70
Target (high)
62.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy9
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 12
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OLMA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56384-0.63 – -0.49-0.51-10.6%00.0%9
Next quarter-0.57906-0.69 – -0.47-0.49-18.2%00.0%9
Current year-2.27-2.62 – -1.95-1.87-21.6%00.0%9
Next year-2.48-3.04 – -1.81-2.27-9.1%23.12M0.0%9

Upgrades and downgrades

The latest rating changes

OLMA analyst upgrades and downgrades
DateFirmActionFromTo
May 13, 2026GuggenheimMaintainedBuyBuy
Mar 27, 2026Wolfe ResearchInitiated—Peer Perform
Mar 18, 2026JP MorganMaintainedOverweightOverweight
Mar 18, 2026Goldman SachsMaintainedBuyBuy
Mar 17, 2026CitigroupMaintainedBuyBuy
Mar 17, 2026GuggenheimMaintainedBuyBuy
Mar 9, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 11, 2026StifelInitiated—Buy
Jan 7, 2026UBSInitiated—Buy
Jan 7, 2026Piper SandlerInitiated—Overweight
Dec 12, 2025CitigroupMaintainedBuyBuy
Dec 11, 2025OppenheimerMaintainedOutperformOutperform
Dec 11, 2025Goldman SachsMaintainedBuyBuy
Dec 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 21, 2025Goldman SachsMaintainedBuyBuy
Nov 18, 2025OppenheimerMaintainedOutperformOutperform
Nov 18, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 18, 2025JP MorganMaintainedOverweightOverweight
Oct 20, 2025HC Wainwright & Co.ReiteratedBuyBuy
Oct 8, 2025GuggenheimInitiated—Buy
Sep 3, 2025OppenheimerMaintainedOutperformOutperform
Aug 14, 2025JP MorganMaintainedOverweightOverweight
Aug 12, 2025CitigroupMaintainedBuyBuy
May 14, 2025Goldman SachsMaintainedBuyBuy
May 14, 2025OppenheimerMaintainedOutperformOutperform
Apr 28, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 28, 2025JP MorganMaintainedOverweightOverweight
Mar 19, 2025OppenheimerReiteratedOutperformOutperform
Mar 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 11, 2025HC Wainwright & Co.ReiteratedBuyBuy